ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,967.84
-0.22%
US Tech 100
21,097.20
-0.29%
Dow Jones
42,206.82
0.08%
Brent Oil
76.095
-1.86%
Bitcoin
103,532.98
-1.11%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Penumbra Inc (PEN) Quote

Penumbra Inc

Penumbra Inc (PEN)

Peninsula Energy Ltd
Pennant International Group Plc
PBF Energy Inc
256.87
-0.14
(-0.05%)
At close: June 20 4:00PM
15 min delayed - Upgrade to Realtime
256.87
0.00
( 0.00% )
After Hours: 4:02PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
256.87
Bid
-
Ask
-
Volume
841,791
256.12 Day's Range 258.11
148.00 52 Week Range 310.00
Market Cap
9.948B
Previous Close
257.01
Open
258.18
Last Trade
1
@
256.87
Last Trade Time
16:04:16
Financial Volume
$ 217,154,686
VWAP
257.9675
Average Volume (3m)
528,756
Shares Outstanding
38,725,940
Dividend Yield
-
PE Ratio
710.14
Earnings Per Share (EPS)
0.36
Revenue
1.19B
Net Profit
14.01M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.penumbrainc.com
Headquarters
Dover, Delaware, USA
Founded
-
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $257.01. Over the last year, Penumbra shares have traded in a share price range of $ 148.00 to $ 310.00.

Penumbra currently has 38,725,940 shares outstanding. The market capitalization of Penumbra is $9.95 billion. Penumbra has a price to earnings ratio (PE ratio) of 710.14.

Ask ADVFN Intelligence (AI)

Penumbra (PEN) Options Flow Summary

PEN Options Flow

Overall Flow

Bullish

Net Premium

26k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

PEN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 18 2025
PEN (-0.05%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 16 2025
PEN (-0.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 13 2025
PEN (-0.05%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 11 2025
PEN (-0.05%)

Form SD - Specialized disclosure report
Edgar (US Regulatory)
May 30 2025
PEN (-0.05%)

Form 8-K - Current report
Edgar (US Regulatory)
May 30 2025
PEN (-0.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 14 2025
PEN (-0.05%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.532.60845250459250.34265.48249.09485220258.49023923CS
4-9.3-3.49400758913266.17275.41249.09455656259.59065865CS
12-10.84-4.04915767061267.71308.99246.45528756276.21944453CS
2616.316.78001330229240.56310222.59494951272.99974142CS
5280.8545.9322804227176.02310148448056239.74252368CS
156134.35109.655566438122.52348.67118.65392308233.33554501CS
26079.0644.4631910466177.81348.67114.865366969230.64998855CS

PEN - Frequently Asked Questions (FAQ)

What is the current Penumbra share price?
The current share price of Penumbra is $ 256.87
How many Penumbra shares are in issue?
Penumbra has 38,725,940 shares in issue
What is the market cap of Penumbra?
The market capitalisation of Penumbra is USD 9.95B
What is the 1 year trading range for Penumbra share price?
Penumbra has traded in the range of $ 148.00 to $ 310.00 during the past year
What is the PE ratio of Penumbra?
The price to earnings ratio of Penumbra is 710.14
What is the cash to sales ratio of Penumbra?
The cash to sales ratio of Penumbra is 8.33
What is the reporting currency for Penumbra?
Penumbra reports financial results in USD
What is the latest annual turnover for Penumbra?
The latest annual turnover of Penumbra is USD 1.19B
What is the latest annual profit for Penumbra?
The latest annual profit of Penumbra is USD 14.01M
What is the registered address of Penumbra?
The registered address for Penumbra is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Penumbra website address?
The website address for Penumbra is www.penumbrainc.com
Which industry sector does Penumbra operate in?
Penumbra operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAMAA Mission Acquisition Corp
$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AAAlcoa Corporation
$ 0.00
(0.00%)
0
AAgilent Technologies
$ 0.00
(0.00%)
0
AAMAA Mission Acquisition Corp
$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AAAlcoa Corporation
$ 0.00
(0.00%)
0
AAgilent Technologies
$ 0.00
(0.00%)
0
AAMAA Mission Acquisition Corp
$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
$ 0.00
(0.00%)
0
AAAlcoa Corporation
$ 0.00
(0.00%)
0
AAgilent Technologies
$ 0.00
(0.00%)
0

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 5 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 5 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 5 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 5 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 5 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 10 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 10 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 10 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

NYSE
PEN
Penumbra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads